DMK PHARMACEUTICALS CORPORATION Intangible Assets, Net (Excluding Goodwill)
DMK PHARMACEUTICALS CORPORATION had Intangible Assets, Net (Excluding Goodwill) of $5.81 million as of 2021-06-30, per its 10-Q filed 2021-11-22.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2021-11-22
- 2021-06-30: Intangible Assets, Net (Excluding Goodwill) $5.81M.
- 2021-03-31: Intangible Assets, Net (Excluding Goodwill) $6.05M.
- 2020-12-31: Intangible Assets, Net (Excluding Goodwill) $6.29M.
- 2020-09-30: Intangible Assets, Net (Excluding Goodwill) $9.68M.
| Period end | Intangible Assets, Net (Excluding Goodwill) |
|---|---|
| 2021-06-30 | $5.81M 10-Q · filed 2021-11-22 |
| 2021-03-31 | $6.05M 10-Q · filed 2021-11-22 |
| 2020-12-31 | $6.29M 10-Q · filed 2021-11-22 |
| 2020-09-30 | $9.68M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $10.16M 10-Q · filed 2020-08-17 |
| 2020-03-31 | $10.65M 10-Q · filed 2020-05-18 |
| 2019-12-31 | $11.13M 10-K · filed 2021-04-15 |
| 2019-09-30 | $11.61M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $12.10M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $12.59M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $13.21M 10-K · filed 2020-03-30 |
| 2018-09-30 | $13.83M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $14.45M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $15.07M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $15.69M 10-K · filed 2019-03-15 |
| 2017-09-30 | $16.31M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $16.92M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $17.53M 10-Q · filed 2017-05-12 |
| 2016-12-31 | $18.14M 10-K · filed 2018-03-16 |
| 2016-09-30 | $18.75M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $19.37M 10-Q · filed 2016-08-15 |
| 2015-12-31 | $7.77M 10-K · filed 2017-03-30 |